The addition of sitagliptin improves glycemic control in patients with type 2 diabetes

被引：0
|
作者：
不详
机构：
来源：
Nature Clinical Practice Endocrinology & Metabolism | 2007年 / 3卷 / 12期
关键词：
D O I：
10.1038/ncpendmet0651
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：790 / 790
相关论文
共 50 条
  • [1] The addition of sitagliptin to ongoing metformin therapy significantly improves glycemic control in Chinese patients with type 2 diabetes*
    Yang, Wenying
    Guan, Yanfen
    Shentu, Yue
    Li, Zhi
    Johnson-Levonas, Amy O.
    Engel, Samuel S.
    Kaufman, Keith D.
    Goldstein, Barry J.
    Alba, Maria
    JOURNAL OF DIABETES, 2012, 4 (03) : 227 - 237
  • [2] Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes
    Tajima, Naoko
    Kadowaki, Takashi
    Okamoto, Taro
    Sato, Asako
    Okuyama, Kotoba
    Minamide, Toshiomi
    Ferreira, Juan Camilo Arjona
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (06) : 595 - 604
  • [3] Effect of sitagliptin on glycemic control in patients with type 2 diabetes
    Rahmah, Abbas Mahdi
    WORLD FAMILY MEDICINE, 2015, 13 (06): : 20 - 25
  • [4] The Addition of Sitagliptin to Metformin and Pioglitazone Therapy Enhances Glycemic Control in Patients with Type 2 Diabetes
    Fonseca, Vivian
    Staels, Bart
    Morgan, Jerry D., II
    Yue Shentu
    Golm, Gregory T.
    Johnson-Levonas, Amy O.
    Kaufman, Keith D.
    Goldstein, Barry J.
    Steinberg, Helmut
    Henry, Robert
    DIABETES, 2011, 60 : A308 - A308
  • [5] Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52weeks
    Kadowaki, Takashi
    Tajima, Naoko
    Odawara, Masato
    Nishii, Mikio
    Taniguchi, Tadaaki
    Ferreira, Juan Camilo Arjona
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (02) : 174 - 181
  • [6] Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus?
    Afshin Salsali
    Richard E Pratley
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 450 - 451
  • [7] Triple combination therapy with sitagliptin, metformin, and rosiglitazone improves glycemic control in patients with type 2 diabetes
    Dobs, Adrian
    Goldstein, Barry J.
    Wieczorek, Leon
    Golm, Gregory
    Davies, Michael J.
    Williams-Herman, Debora
    Kaufman, Keith D.
    Amatruda, John M.
    Camilo, Juan
    Ferriera, Arjona
    DIABETES, 2008, 57 : A595 - A596
  • [8] A Combination Therapy with Liraglutide and Sitagliptin Improves Glycemic Control in Japanese Patients with Type 2 Diabetes Mellitus
    Matsuhashi, Yuki
    Chikazawa, Shinji
    Osonoi, Shou
    Mizushiri, Satoru
    Yamaichi, Masato
    Otaka, Hideyuki
    Takahashi, Kazuhisa
    Kanba, Aya
    Matsumura, Koki
    Matsuki, Kota
    Sato, Eri
    Tanabe, Jutaro
    Yanagimachi, Miyuki
    Murakami, Hiroshi
    Daimon, Makoto
    DIABETES, 2017, 66 : A629 - A629
  • [9] Combination of liraglutide and sitagliptin therapy improves glycemic control in Japanese patients with type 2 diabetes mellitus
    Matsuhashi, Yuki
    Chikazawa, Shinji
    Otaka, Hideyuki
    Takahashi, Kazuhisa
    Kabma, Aya
    Matsumura, Koki
    Matsuki, Kota
    Sato, Eri
    Tanabe, Jutaro
    Yanagimachi, Miyuki
    Murakami, Hiroshi
    Daimon, Makoto
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S101 - S101
  • [10] Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus? Commentary
    Salsali, Afshin
    Pratley, Richard E.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (06): : 450 - 451
12345